Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 6 | 2026 | 1455 | 1.760 |
Why?
|
| Quality of Health Care | 10 | 2026 | 407 | 1.610 |
Why?
|
| Reimbursement, Incentive | 6 | 2015 | 47 | 1.400 |
Why?
|
| Contact Tracing | 2 | 2022 | 60 | 1.320 |
Why?
|
| Self-Management | 3 | 2022 | 120 | 1.310 |
Why?
|
| Physicians | 6 | 2023 | 626 | 1.250 |
Why?
|
| Primary Health Care | 14 | 2025 | 770 | 1.200 |
Why?
|
| Diabetes Complications | 2 | 2026 | 197 | 1.140 |
Why?
|
| Diabetes Mellitus | 7 | 2018 | 888 | 1.130 |
Why?
|
| Patient Care Team | 10 | 2025 | 558 | 1.110 |
Why?
|
| Medicare Part C | 2 | 2026 | 35 | 0.960 |
Why?
|
| Hypertension | 8 | 2016 | 1352 | 0.890 |
Why?
|
| Hospitals, Veterans | 12 | 2024 | 335 | 0.810 |
Why?
|
| Pharmacies | 1 | 2023 | 15 | 0.790 |
Why?
|
| Pharmaceutical Services | 1 | 2023 | 34 | 0.780 |
Why?
|
| Pharmacy | 1 | 2023 | 18 | 0.780 |
Why?
|
| Guideline Adherence | 9 | 2021 | 387 | 0.780 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2026 | 266 | 0.760 |
Why?
|
| United States | 27 | 2026 | 11893 | 0.760 |
Why?
|
| Early Detection of Cancer | 1 | 2026 | 414 | 0.720 |
Why?
|
| Social Support | 2 | 2020 | 369 | 0.720 |
Why?
|
| Public Health | 2 | 2022 | 269 | 0.700 |
Why?
|
| Attitude of Health Personnel | 4 | 2024 | 700 | 0.700 |
Why?
|
| Health Care Costs | 1 | 2025 | 406 | 0.690 |
Why?
|
| Pandemics | 6 | 2023 | 1112 | 0.690 |
Why?
|
| Disaster Planning | 1 | 2021 | 68 | 0.670 |
Why?
|
| United States Department of Veterans Affairs | 12 | 2025 | 711 | 0.670 |
Why?
|
| Cyclonic Storms | 1 | 2021 | 82 | 0.650 |
Why?
|
| Disasters | 1 | 2021 | 101 | 0.650 |
Why?
|
| Investments | 1 | 2020 | 12 | 0.640 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2026 | 509 | 0.640 |
Why?
|
| Patient-Centered Care | 4 | 2024 | 237 | 0.620 |
Why?
|
| Education | 1 | 2020 | 112 | 0.610 |
Why?
|
| Peer Group | 1 | 2020 | 128 | 0.570 |
Why?
|
| Self Care | 1 | 2020 | 231 | 0.550 |
Why?
|
| Quality Indicators, Health Care | 3 | 2022 | 237 | 0.550 |
Why?
|
| Residence Characteristics | 1 | 2020 | 293 | 0.540 |
Why?
|
| Humans | 60 | 2026 | 130055 | 0.540 |
Why?
|
| Veterans | 3 | 2020 | 1752 | 0.540 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2022 | 907 | 0.530 |
Why?
|
| Psychotherapy, Group | 1 | 2018 | 58 | 0.520 |
Why?
|
| Problem Solving | 2 | 2020 | 61 | 0.520 |
Why?
|
| Aged | 25 | 2026 | 20816 | 0.520 |
Why?
|
| Health Status Disparities | 1 | 2020 | 278 | 0.510 |
Why?
|
| Motivation | 2 | 2016 | 328 | 0.510 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 115 | 0.500 |
Why?
|
| Education, Medical | 1 | 2020 | 289 | 0.480 |
Why?
|
| Telemedicine | 1 | 2022 | 525 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 337 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 348 | 0.450 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 69 | 0.450 |
Why?
|
| Data Collection | 2 | 2023 | 370 | 0.450 |
Why?
|
| Qualitative Research | 5 | 2024 | 709 | 0.440 |
Why?
|
| Middle Aged | 26 | 2026 | 28303 | 0.440 |
Why?
|
| Male | 37 | 2026 | 64375 | 0.430 |
Why?
|
| Mental Disorders | 1 | 2022 | 901 | 0.430 |
Why?
|
| Female | 35 | 2026 | 70227 | 0.410 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 2593 | 0.400 |
Why?
|
| Ambulatory Care Facilities | 2 | 2016 | 231 | 0.400 |
Why?
|
| Texas | 6 | 2026 | 3655 | 0.380 |
Why?
|
| Communicable Disease Control | 4 | 2023 | 139 | 0.380 |
Why?
|
| Coronary Disease | 5 | 2014 | 627 | 0.360 |
Why?
|
| Health Services Accessibility | 4 | 2025 | 698 | 0.360 |
Why?
|
| Curriculum | 3 | 2024 | 792 | 0.360 |
Why?
|
| Delivery of Health Care | 3 | 2018 | 682 | 0.360 |
Why?
|
| Lost to Follow-Up | 1 | 2012 | 32 | 0.360 |
Why?
|
| Longitudinal Studies | 3 | 2026 | 1482 | 0.350 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2012 | 40 | 0.350 |
Why?
|
| Cholesterol, LDL | 6 | 2014 | 605 | 0.340 |
Why?
|
| Comorbidity | 5 | 2026 | 1584 | 0.310 |
Why?
|
| Program Evaluation | 2 | 2018 | 443 | 0.300 |
Why?
|
| Hypolipidemic Agents | 2 | 2013 | 195 | 0.280 |
Why?
|
| Electronic Health Records | 1 | 2015 | 830 | 0.270 |
Why?
|
| Hypercholesterolemia | 3 | 2011 | 231 | 0.270 |
Why?
|
| Education, Distance | 2 | 2019 | 69 | 0.270 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 4035 | 0.270 |
Why?
|
| Cholesterol | 3 | 2018 | 537 | 0.260 |
Why?
|
| Interprofessional Relations | 3 | 2019 | 149 | 0.260 |
Why?
|
| Self-Help Groups | 1 | 2007 | 14 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2026 | 6763 | 0.250 |
Why?
|
| Public-Private Sector Partnerships | 3 | 2022 | 17 | 0.250 |
Why?
|
| Goals | 2 | 2022 | 126 | 0.250 |
Why?
|
| Adult | 15 | 2026 | 30999 | 0.250 |
Why?
|
| Social Identification | 1 | 2007 | 22 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 7 | 2016 | 1281 | 0.240 |
Why?
|
| Infant, Premature | 1 | 2012 | 861 | 0.240 |
Why?
|
| Housing | 1 | 2026 | 74 | 0.230 |
Why?
|
| Safety-net Providers | 1 | 2026 | 89 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2016 | 744 | 0.220 |
Why?
|
| Lawyers | 1 | 2024 | 5 | 0.220 |
Why?
|
| Needs Assessment | 3 | 2020 | 173 | 0.210 |
Why?
|
| Blood Pressure | 3 | 2016 | 1344 | 0.210 |
Why?
|
| Lipoproteins | 2 | 2018 | 182 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2022 | 1241 | 0.200 |
Why?
|
| Attitude to Health | 1 | 2005 | 246 | 0.200 |
Why?
|
| Internet | 1 | 2007 | 418 | 0.200 |
Why?
|
| Organizational Culture | 1 | 2024 | 94 | 0.200 |
Why?
|
| Students | 2 | 2022 | 247 | 0.200 |
Why?
|
| Opioid-Related Disorders | 1 | 2007 | 296 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 513 | 0.190 |
Why?
|
| Medically Underserved Area | 1 | 2023 | 87 | 0.190 |
Why?
|
| Community Participation | 1 | 2023 | 42 | 0.190 |
Why?
|
| Logistic Models | 5 | 2018 | 1794 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 72 | 0.180 |
Why?
|
| Universities | 1 | 2022 | 125 | 0.180 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3780 | 0.180 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 2107 | 0.170 |
Why?
|
| Health Equity | 1 | 2023 | 77 | 0.170 |
Why?
|
| Climate Change | 1 | 2021 | 65 | 0.170 |
Why?
|
| Interviews as Topic | 2 | 2024 | 455 | 0.160 |
Why?
|
| Clinical Competence | 4 | 2019 | 1042 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2016 | 774 | 0.150 |
Why?
|
| Inservice Training | 1 | 2019 | 56 | 0.150 |
Why?
|
| Lipids | 2 | 2013 | 566 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17538 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2020 | 209 | 0.140 |
Why?
|
| Nurses | 1 | 2019 | 65 | 0.140 |
Why?
|
| Minority Groups | 1 | 2020 | 259 | 0.140 |
Why?
|
| Intersectoral Collaboration | 1 | 2018 | 18 | 0.140 |
Why?
|
| Physician Incentive Plans | 2 | 2009 | 12 | 0.140 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 165 | 0.140 |
Why?
|
| Staff Development | 1 | 2018 | 50 | 0.130 |
Why?
|
| Health Personnel | 1 | 2023 | 538 | 0.130 |
Why?
|
| Prevalence | 2 | 2022 | 2686 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2026 | 1212 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 90 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2026 | 3026 | 0.130 |
Why?
|
| Patient Participation | 1 | 2020 | 252 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 502 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2024 | 708 | 0.120 |
Why?
|
| Health Services Research | 2 | 2014 | 178 | 0.120 |
Why?
|
| Dyslipidemias | 2 | 2016 | 249 | 0.110 |
Why?
|
| Risk Factors | 4 | 2020 | 10956 | 0.110 |
Why?
|
| Veterans Health | 1 | 2016 | 170 | 0.110 |
Why?
|
| Research Report | 1 | 2014 | 73 | 0.100 |
Why?
|
| Cholesterol, HDL | 2 | 2014 | 384 | 0.100 |
Why?
|
| Arthritis | 2 | 2011 | 82 | 0.100 |
Why?
|
| Publishing | 1 | 2014 | 105 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 414 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 270 | 0.090 |
Why?
|
| Social Isolation | 2 | 2022 | 49 | 0.090 |
Why?
|
| Hypotension | 1 | 2013 | 186 | 0.090 |
Why?
|
| Sample Size | 1 | 2011 | 84 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2014 | 289 | 0.090 |
Why?
|
| Life Expectancy | 1 | 2012 | 63 | 0.090 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 308 | 0.080 |
Why?
|
| Infant Mortality | 1 | 2012 | 181 | 0.080 |
Why?
|
| Young Adult | 2 | 2022 | 9978 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2012 | 169 | 0.080 |
Why?
|
| Random Allocation | 1 | 2011 | 409 | 0.080 |
Why?
|
| Risk | 1 | 2012 | 723 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2012 | 1210 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 350 | 0.070 |
Why?
|
| Sex Factors | 3 | 2021 | 1343 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2013 | 12821 | 0.070 |
Why?
|
| Risk Adjustment | 2 | 2007 | 55 | 0.070 |
Why?
|
| Internal Medicine | 2 | 2024 | 124 | 0.070 |
Why?
|
| Disease Management | 1 | 2011 | 553 | 0.060 |
Why?
|
| Research Design | 1 | 2011 | 711 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 645 | 0.060 |
Why?
|
| Financing, Government | 1 | 2007 | 33 | 0.060 |
Why?
|
| Narration | 1 | 2007 | 32 | 0.060 |
Why?
|
| Mortality | 2 | 2007 | 263 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 890 | 0.060 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 222 | 0.060 |
Why?
|
| Age Factors | 3 | 2021 | 2822 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2007 | 146 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2016 | 1227 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 58 | 0.060 |
Why?
|
| Algorithms | 1 | 2012 | 1662 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2005 | 70 | 0.050 |
Why?
|
| Organizational Innovation | 1 | 2024 | 41 | 0.050 |
Why?
|
| Focus Groups | 1 | 2005 | 239 | 0.050 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2023 | 7 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2004 | 163 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2005 | 182 | 0.050 |
Why?
|
| Aspirin | 1 | 2004 | 213 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2004 | 189 | 0.050 |
Why?
|
| Depression | 1 | 2011 | 1313 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 268 | 0.050 |
Why?
|
| Loneliness | 1 | 2022 | 34 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 461 | 0.040 |
Why?
|
| Marital Status | 1 | 2021 | 33 | 0.040 |
Why?
|
| Independent Living | 1 | 2021 | 64 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 439 | 0.040 |
Why?
|
| Immunization Programs | 1 | 2021 | 68 | 0.040 |
Why?
|
| Food Supply | 1 | 2021 | 91 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 275 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 686 | 0.040 |
Why?
|
| Social Networking | 1 | 2019 | 14 | 0.040 |
Why?
|
| Group Processes | 1 | 2019 | 48 | 0.040 |
Why?
|
| Personnel Turnover | 1 | 2019 | 16 | 0.040 |
Why?
|
| Triglycerides | 2 | 2012 | 603 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2891 | 0.030 |
Why?
|
| Life Style | 1 | 2021 | 450 | 0.030 |
Why?
|
| Peer Review | 1 | 2016 | 34 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 246 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 6165 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 230 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 5164 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 317 | 0.030 |
Why?
|
| Family Practice | 1 | 2011 | 82 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2012 | 226 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 129 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 185 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2014 | 324 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2011 | 124 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 674 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2011 | 5033 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 239 | 0.020 |
Why?
|
| Endocrinology | 1 | 2011 | 124 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2012 | 336 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2007 | 8 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 114 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 20797 | 0.020 |
Why?
|
| Cardiology | 1 | 2011 | 514 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 461 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2006 | 142 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4845 | 0.010 |
Why?
|
| Total Quality Management | 1 | 2004 | 22 | 0.010 |
Why?
|
| Utilization Review | 1 | 2004 | 39 | 0.010 |
Why?
|
| Medical Audit | 1 | 2004 | 97 | 0.010 |
Why?
|
| Patient Selection | 1 | 2004 | 722 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8547 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2290 | 0.010 |
Why?
|